Alecta to tender its entire 9.13 per cent stake in Rhön-Klinikum AG

Monday, 18 June 2012
Alecta has, after in-depth discussions with all parties involved in the transaction, today decided to tender all of its shares in Rhön-Klinikum to Fresenius.
The industrial logic for combining Fresenius-Helios and Rhön-Klinikum is strong. Both companies are acting from a position of strength and complement each other at the same time. Therefore this combination has the potential to create an even stronger entity and offers opportunities for significant synergies.

“We are confident that Fresenius-Helios and Rhön-Klinikum together will reach the targeted structure and results set forth for this transaction. In addition, we are happy to support Eugen Münch, founder of Rhön-Klinikum, in his vision to create an integrated health care system focused on the patients’ needs, by treating the patient at the right facility at the right time”, says Leif Törnvall, Portfolio Manager at Alecta.

Alecta has been a shareholder in both Rhön-Klinikum and Fresenius for many years.

“These are two quality companies. We highly regard them for their excellent track records, proven business models, reliable managements and significant growth opportunities”, says Marcus Lüttgen, Co-Manager at Alecta.

What do you think about this article or us? Please leave a comment. Thank you!